Skip to Content
Merck
CN
  • Comparison of amitriptyline metabolism in hepatocytes from streptozocin-induced diabetic rats and from non-diabetic rats.

Comparison of amitriptyline metabolism in hepatocytes from streptozocin-induced diabetic rats and from non-diabetic rats.

Cell biology and toxicology (1997-02-01)
F Coudoré, A Besson, R Shrivastava, A Chevalier, A Eschalier, J Lavarenne, R Massingham, J Fialip
ABSTRACT

Biotransformation of amitriptyline (AMI) was studied at different intervals in freshly isolated hepatocytes from healthy or streptozocin-induced diabetic rats in order to investigate the influence of the diabetic state. Levels of free and conjugated AMI, demethylated and hydroxylated metabolites, were assessed by HPLC analysis. In hepatocytes isolated from diabetic rats, AMI was less completely metabolized and the demethylation reaction became more important than in non-diabetic rat hepatocytes. Although the proportions of hydroxylated metabolites decreased in diabetic rats, it always remained predominant. Furthermore, glucuronidation of metabolites was greater, especially for (Z)-10-hydroxynortriptyline in diabetic animals.

MATERIALS
Product Number
Brand
Product Description

Supelco
Amitriptyline metabolite, (±)-E-10-hydroxylated-, analytical standard